Israel Rituximab Market (2025-2031) | Forecast, Outlook, Growth, Competitive Landscape, Size & Revenue, Trends, Industry, Analysis, Value, Segmentation, Share, Companies

Market Forecast By Route of Administration (Subcutaneous, Intravenous, Parenteral), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Others) And Competitive Landscape
Product Code: ETC7661125 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Israel Rituximab Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The import of rituximab to Israel in 2024 saw significant contributions from top exporting countries including Lithuania, Canada, Ireland, Germany, and China. Despite high concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the market continued to grow steadily with a Compound Annual Growth Rate (CAGR) of 10.09% from 2020 to 2024. The growth momentum remained strong in 2024 with a growth rate of 7.1% compared to the previous year, reflecting a promising outlook for the rituximab market in Israel.

Israel Rituximab Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • Israel Rituximab Market Outlook
  • Market Size of Israel Rituximab Market, 2024
  • Forecast of Israel Rituximab Market, 2031
  • Historical Data and Forecast of Israel Rituximab Revenues & Volume for the Period 2021- 2031
  • Israel Rituximab Market Trend Evolution
  • Israel Rituximab Market Drivers and Challenges
  • Israel Rituximab Price Trends
  • Israel Rituximab Porter's Five Forces
  • Israel Rituximab Industry Life Cycle
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Intravenous for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Non-Hodgkin's Lymphoma for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Chronic Lymphocytic Leukemia for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Rheumatoid Arthritis for the Period 2021- 2031
  • Historical Data and Forecast of Israel Rituximab Market Revenues & Volume By Others for the Period 2021- 2031
  • Israel Rituximab Import Export Trade Statistics
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Application
  • Israel Rituximab Top Companies Market Share
  • Israel Rituximab Competitive Benchmarking By Technical and Operational Parameters
  • Israel Rituximab Company Profiles
  • Israel Rituximab Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Israel Rituximab Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Israel Rituximab Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Rituximab Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Rituximab Market Revenues & Volume, 2021 & 2031F

3.3 Israel Rituximab Market - Industry Life Cycle

3.4 Israel Rituximab Market - Porter's Five Forces

3.5 Israel Rituximab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 Israel Rituximab Market Revenues & Volume Share, By Application, 2021 & 2031F

4 Israel Rituximab Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of autoimmune diseases in Israel

4.2.2 Growing awareness and adoption of rituximab therapy in the Israeli healthcare system

4.2.3 Favorable government policies and regulations supporting the use of rituximab in Israel

4.3 Market Restraints

4.3.1 High cost associated with rituximab treatment may limit access for some patients

4.3.2 Potential side effects and safety concerns related to rituximab therapy

4.3.3 Competition from alternative treatments or therapies in the Israeli market

5 Israel Rituximab Market Trends

6 Israel Rituximab Market, By Types

6.1 Israel Rituximab Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 Israel Rituximab Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 Israel Rituximab Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.1.4 Israel Rituximab Market Revenues & Volume, By Intravenous, 2021- 2031F

6.1.5 Israel Rituximab Market Revenues & Volume, By Parenteral, 2021- 2031F

6.2 Israel Rituximab Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Rituximab Market Revenues & Volume, By Non-Hodgkin's Lymphoma, 2021- 2031F

6.2.3 Israel Rituximab Market Revenues & Volume, By Chronic Lymphocytic Leukemia, 2021- 2031F

6.2.4 Israel Rituximab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F

6.2.5 Israel Rituximab Market Revenues & Volume, By Others, 2021- 2031F

7 Israel Rituximab Market Import-Export Trade Statistics

7.1 Israel Rituximab Market Export to Major Countries

7.2 Israel Rituximab Market Imports from Major Countries

8 Israel Rituximab Market Key Performance Indicators

8.1 Number of healthcare facilities offering rituximab therapy in Israel

8.2 Patient adherence and compliance rates to rituximab treatment

8.3 Number of clinical trials or research studies on rituximab conducted in Israel

9 Israel Rituximab Market - Opportunity Assessment

9.1 Israel Rituximab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 Israel Rituximab Market Opportunity Assessment, By Application, 2021 & 2031F

10 Israel Rituximab Market - Competitive Landscape

10.1 Israel Rituximab Market Revenue Share, By Companies, 2024

10.2 Israel Rituximab Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All